Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells

Overview of attention for article published in Clinical Cancer Research, October 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 8 X users

googleplus: 1 Google+ user

Readers on

mendeley: 41 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 13,745 followers.

RT @cancerscnews: Joining forces to stop CSC: Dual Src & MEK Inhibition Decreases #OvarianCancer Growth and Targets Tumor Initiating Stem-L…

Joining forces to stop CSC: Dual Src & MEK Inhibition Decreases #OvarianCancer Growth and Targets Tumor Initiating Stem-Like Cells @MDAndersonNews @univmiami @Penn @TheWistar https://t.co/7JdhaNgnPZ https://t.co/nyUyTRcYXF

Dual Src and MEK inhibition decreases ovarian cancer growth and targets tumor initiating stem-like cells https://t.co/8GZGagy0br #cancerstemcells #ovariancancer

Dual Src and MEK inhibition decreases ovarian cancer growth and targets tumor initiating stem-like cells. https://t.co/Ty7YwTu655

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.